The Rs. 165 cr. IPO of Gaudium IVF & Women Health is witnessing encouraging investor interest during the ongoing bidding process. Grey market data shows the shares trading at around an 11% premium over the issue price.
Brokerages are evaluating the company’s positioning in the fast-growing fertility services segment. Subscription trends across investor categories will determine the final demand outlook.
The IPO’s performance is being closely tracked amid rising interest in healthcare-focused listings.
